Archives
OCT2 and MATE1 Inhibition by 5-HT3 Antagonists
2026-08-31
George et al. evaluated how five 5-HT3 antagonist antiemetics inhibit the renal organic cation transport system formed by OCT2 and MATE1. Their cell-based experiments identified compound-specific inhibition patterns and showed that ondansetron can disrupt coordinated basolateral-to-apical transport, providing a mechanistic basis for potential interactions involving renally secreted cationic drugs.
Streptozotocin: From β-Cell Injury to Neuropathy
2026-08-31
Streptozotocin (STZ) is more than a tool for creating hyperglycemia: it is a mechanistically defined perturbation that can connect β-cell loss with inflammatory complications such as painful diabetic neuropathy. This thought-leadership guide shows how translational researchers can use STZ with greater experimental precision, integrate TBK1–microglia biology, and design models that better support therapeutic decisions.
Cyclic Pifithrin-α Hydrobromide: Assay Logic
2026-08-30
Cyclic Pifithrin-α hydrobromide is a p53 inhibitor for separating p53-dependent transcription from downstream cell fate decisions. This article connects its use to neuroinflammation research while defining practical controls, assay boundaries, and interpretation standards.
OCT2 and MATE1 Inhibition by Antiemetics
2026-08-29
George et al. systematically compared five 5-HT3 antagonists as inhibitors of the renal organic cation transport pathway mediated by OCT2 and MATE1. Their combination of transporter-specific uptake assays and a directional MDCK transcellular model shows that antiemetics can differentially disrupt cationic drug secretion, supporting closer evaluation of transporter-mediated drug interactions.
Tofacitinib citrate: Immune Assay Workflows
2026-08-28
Build dose-resolved immune and endothelial assays with Tofacitinib citrate (CP-690550 citrate), from JAK-STAT pathway studies to cytokine-driven vascular models. Learn how to separate anti-inflammatory activity from adhesion, coagulation, and cytotoxicity phenotypes.
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-08-28
This scenario-based guide explains how the One-step TUNEL Cy3 Apoptosis Detection Kit, SKU K1134, can address common problems in DNA fragmentation and apoptosis workflows. It covers assay principles, sample compatibility, controls, interpretation, and practical vendor-selection criteria for research teams.
The 4Q Principle for Stable mRNA Delivery
2026-08-27
The 2024 Chemistry of Materials study introduces a 4Q framework that treats mRNA delivery as a sequence of stability, diffusion, cellular entry, and intracellular release steps. Its disulfide-containing polycatechol, PBD, produced room-temperature-stable polyplexes and substantially higher in vivo fluorescence than a jetPEI benchmark, offering a practical design logic for nonviral mRNA vectors.
SPRTN Ubiquitin Binding and DPC Proteolysis
2026-08-27
A 2024 bioRxiv preprint identifies a ubiquitin-binding interface within the catalytic SprT region of SPRTN and links ubiquitin-chain recognition to selective DNA-protein crosslink proteolysis. The work provides a mechanistic explanation for how SPRTN distinguishes polyubiquitinated DPCs from unmodified lesions and activates proteolysis approximately 67-fold more strongly.
DPPH Radical: Mechanism, Assay & Evidence
2026-08-26
DPPH, or 2,2-Diphenyl-1-Picrylhydrazyl, is a nitrogen-centered stable radical used for rapid in vitro antioxidant screening. Its violet-to-yellow reduction signal supports compound and extract ranking, but it does not by itself establish cellular antioxidant efficacy or a therapeutic mechanism.
Formononetin Protects Against Oxaliplatin Neurotoxicity
2026-08-26
The reference study identifies formononetin as a candidate neuroprotectant that reduces oxaliplatin-induced oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway. Its most important translational finding is that protection of dorsal root ganglion neurons was achieved without reducing oxaliplatin or paclitaxel anticancer activity in the tested cancer cell models.
Jasplakinolide: Actin Polymerization Inducer
2026-08-25
Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing F-actin. Its competitive binding to actin, ion-dependent behavior, and DMSO-compatible handling make it a useful actin cytoskeleton research tool when paired with appropriate controls.
131I-MIBG–PARP Synergy in PPGL Models
2026-08-25
Song et al. investigated whether the radionuclide therapy 131I-MIBG could work synergistically with the PARP inhibitor fluzoparib in norepinephrine transporter-overexpressing pheochromocytoma and paraganglioma models. The combination increased G2/M arrest and apoptosis, while SDHB suppression selectively heightened sensitivity to fluzoparib rather than changing the response to 131I-MIBG.
Estradiol Benzoate: From Receptor Signal to Translation
2026-08-24
A mechanistic and translational guide to using Estradiol Benzoate as an estrogen receptor alpha agonist, with practical assay design, quality considerations, and lessons from structure-based NSP15 inhibitor screening.
REV1–DHX36 Control of G-Quadruplex Replication
2026-08-24
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings establish a two-tier mechanism for G4 tolerance and clarify how loss of REV1 reshapes replication, mutagenesis, and ATM/ATR DNA damage response signaling.
Dual Luciferase Reporter Gene System Guide
2026-08-23
The Dual Luciferase Reporter Gene System pairs firefly and Renilla signals to distinguish true promoter effects from sample-to-sample variation. This guide translates the system into practical promoter-mapping, transcription-factor, and high-throughput workflows, with troubleshooting informed by a recent tomato aluminium-tolerance study.
728 records 10/49 page Previous Next First page 上5页 678910 下5页 Last page